John C. Williams
29Patents
6h-index
24Co-inventors
69Inventor score
Filing activity: Oct 28, 1976 → Jul 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4076380A | Graded index optical fiber | Physics | 39 | Expired |
| US9574014B2 | Chimeric antigen receptor compositions | Chemistry; Metallurgy | 35 | Active |
| US8962804B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 33 | Active |
| US8895702B2 | Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies | Chemistry; Metallurgy | 19 | Active |
| US10357571B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 13 | Active |
| US6881008B1 | Particle binding compositions and methods of making and using such compositions | Fixed Constructions | 7 | Expired |
| US8658774B2 | Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US9669108B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11116834B2 | Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy | Chemistry; Metallurgy | 5 | Active |
| US9193791B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 4 | Active |
| US7021864B2 | Soil binding and revegetation compositions and methods of making and using such compositions | Fixed Constructions | 3 | Expired |
| US9428553B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10590205B2 | Chimeric antigen receptor compositions | Chemistry; Metallurgy | 2 | Active |
| US10414814B2 | Tumor-selective CTLA-4 antagonists | Chemistry; Metallurgy | 2 | Active |
| US10689423B2 | CTLA4-binding protein peptide-linker masks | Chemistry; Metallurgy | 1 | Active |
| US11690908B2 | Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy | Chemistry; Metallurgy | 1 | Active |
| US9096844B2 | Photocleavable linker | Physics | 1 | Active |
| US11926652B2 | CTLA4-binding protein peptide-linker masks | Chemistry; Metallurgy | 0 | Active |
| US12384845B2 | Activatable masked anti-CTLA4 binding proteins | Chemistry; Metallurgy | 0 | Active |
| US11311622B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 0 | Active |
| US11279752B2 | Tumor-selective CTLA-4 antagonists | Chemistry; Metallurgy | 0 | Active |
| US12358998B2 | Anti-CD6 antibody-growth factor complex for treating autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US12161714B2 | Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy | Chemistry; Metallurgy | 0 | Active |
| US12060435B2 | Multi-specific ligand binders | Chemistry; Metallurgy | 0 | Active |
| US11246942B2 | Meditopes and meditope-binding antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.